Shortage on the way

The TGA says it is investigating a solution to a predicted abatacept shortage The Therapeutic Goods Administration has released a statement saying that it is aware that shortages of both Orencia (abatacept) 125 mg products, the ClickJect prefilled autoinjector and prefilled syringe for subcutaneous injection, are anticipated from early to mid-June 2024. “To minimise the impact

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Should nicotine vaping products go S3?
Next ‘Why not fund that pharmacist to become a doctor?’